DEPO PRODASONE

This brand name is authorized in France, Tunisia.

Active ingredients

The drug DEPO PRODASONE contains one active pharmaceutical ingredient (API):

`1`	Medroxyprogesterone UNII `C2QI4IOI2G` - MEDROXYPROGESTERONE ACETATE
	Medroxyprogesterone acetate exerts anti-oestrogenic, anti-androgenic and antigonadotrophic effects.
	Read more about Medroxyprogesterone

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
L02AB02	Medroxyprogesterone	L Antineoplastic and immunomodulating agents → L02 Endocrine therapy → L02A Hormones and related agents → L02AB Progestogens
Discover more medicines within L02AB02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
FR	Base de données publique des médicaments	62582326
TN	Direction de la Pharmacie et du Médicament	10803221H

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.